JPH11326325A - Immunity inspection body with determination efficiency - Google Patents
Immunity inspection body with determination efficiencyInfo
- Publication number
- JPH11326325A JPH11326325A JP13021898A JP13021898A JPH11326325A JP H11326325 A JPH11326325 A JP H11326325A JP 13021898 A JP13021898 A JP 13021898A JP 13021898 A JP13021898 A JP 13021898A JP H11326325 A JPH11326325 A JP H11326325A
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- detection
- amount
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000007689 inspection Methods 0.000 title abstract description 3
- 230000036039 immunity Effects 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 claims abstract description 78
- 239000000427 antigen Substances 0.000 claims abstract description 77
- 102000036639 antigens Human genes 0.000 claims abstract description 76
- 108091007433 antigens Proteins 0.000 claims abstract description 74
- 238000012360 testing method Methods 0.000 claims abstract description 41
- 239000013566 allergen Substances 0.000 claims abstract description 25
- 238000011161 development Methods 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 8
- 230000001900 immune effect Effects 0.000 claims description 17
- 238000003018 immunoassay Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 238000011144 upstream manufacturing Methods 0.000 claims description 7
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 239000010419 fine particle Substances 0.000 claims description 3
- 238000012790 confirmation Methods 0.000 abstract description 13
- 238000007654 immersion Methods 0.000 abstract description 6
- 239000007788 liquid Substances 0.000 abstract description 6
- 239000003086 colorant Substances 0.000 abstract description 3
- 239000003550 marker Substances 0.000 abstract 5
- 230000003100 immobilizing effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 15
- 239000011521 glass Substances 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 241000238876 Acari Species 0.000 description 5
- 238000003317 immunochromatography Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 239000012488 sample solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000218645 Cedrus Species 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 241000256111 Aedes <genus> Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010048908 Seasonal allergy Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000029771 childhood onset asthma Diseases 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000009597 pregnancy test Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Sampling And Sample Adjustment (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、抗原抗体反応によ
り被検体、特にスギ、ダニ等のアレルゲンを検出する免
疫検査体に関する。特に被検体の存在量範囲を評価する
ことのできる機能を組み込んだ定量性を付与した免疫検
査体に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an immunological test for detecting an allergen such as a test substance, particularly cedar or tick, by an antigen-antibody reaction. In particular, the present invention relates to a quantitatively imparted immunological test object incorporating a function capable of evaluating the range of abundance of a subject.
【0002】[0002]
【従来の技術】スギやヒノキあるいはセイタカアワダチ
ソウなどの植物花粉による花粉症、屋内塵中に生息する
ダニ類が主要な原因となって引き起こされる小児喘息や
アトピー性皮膚炎などのアレルギー疾患により苦痛を受
けている人が著しく増加している。アレルギー疾患の症
状改善には、患者をアレルギーから遠ざけることが最も
有効な手段であり、そのためにはアレルゲンの存在場所
と存在量を把握する必要がある。2. Description of the Related Art Pain is caused by pollinosis caused by plant pollen such as cedar, cypress, or Aedes chinensis, and allergic diseases such as pediatric asthma and atopic dermatitis caused mainly by mites living in indoor dust. The number of recipients has increased significantly. Keeping patients away from allergies is the most effective way to improve the symptoms of allergic diseases, and it is necessary to understand the location and amount of allergens.
【0003】このような目的で、最近、掃除機に取り付
けて屋内のハウスダストを採取するダニ捕集器と、ダニ
を捕集したフィルターからダニの抗原量を測定するシス
テムが発売されている。これらの装置は、まず掃除機で
検体を採取し、次いでダニを捕集したフィルターを抗原
溶解液に浸けて抗原を溶解し、最後にこの抗原を溶解し
た液をエンザイムイムノアッセイ(EIA)法またはイ
ムノクロマト法で検査するものである。[0003] For this purpose, a mite collector for collecting house dust in a room attached to a vacuum cleaner and a system for measuring the amount of mite antigen from a filter for collecting mite have recently been put on the market. In these devices, a sample is first collected by a vacuum cleaner, then the filter that has collected the mites is immersed in an antigen solution to dissolve the antigen, and finally, the solution in which the antigen is dissolved is used for enzyme immunoassay (EIA) or immunochromatography. Inspection by law.
【0004】このうち、抗原の存在を検査する方法とし
て望ましいものはOTC用の妊娠検査薬等に使用されて
いるイムノクロマト法がある。即ち、アレルゲンに対す
る2種類の抗体があって、一方は検査基材に固定されて
おり、他方は金コロイド、着色ラテックス等で標識され
ており、且つ溶解可能な状態で保持されている。これら
2種類の抗体は検査対象とする抗原の異なるエピトープ
に結合することができる。また標識抗体に対する抗体
が、固定された抗アレルゲン抗体の更に下流に固定され
ている。検体液が供与され、検体液中にアレルゲンが存
在する場合、標識抗体と抗原が複合体(ラベル化抗原)
を形成し、更に抗アレルゲン抗体固定部(即ち抗原検出
部)でこの抗体とも結合してサンドイッチ複合体を形成
し、肉眼で認識される。[0004] Among them, a preferable method for testing the presence of an antigen is an immunochromatography method used as a pregnancy test drug for OTC. That is, there are two types of antibodies against the allergen, one is fixed to the test substrate, the other is labeled with colloidal gold, colored latex, etc., and is held in a soluble state. These two antibodies can bind to different epitopes of the antigen to be tested. Further, an antibody against the labeled antibody is immobilized further downstream of the immobilized anti-allergen antibody. When a sample solution is provided and the sample solution contains an allergen, a labeled antibody and antigen complex (labeled antigen)
Is formed, and further bound to this antibody at the anti-allergen antibody fixing portion (that is, the antigen detecting portion) to form a sandwich complex, which is visually recognized.
【0005】しかしながら上記のような従来のイムノク
ロマト法は以下の欠点を有する。 検出部が単一のゾーンでできているため、抗原の有
無の判定は容易であるが、抗原の量については検出部の
呈色の濃淡の目視評価に依存する。 目視評価は観察者により異なる判定が出る可能性が
ある。However, the conventional immunochromatography method as described above has the following disadvantages. Since the detection unit is formed of a single zone, it is easy to determine the presence or absence of the antigen, but the amount of the antigen depends on the visual evaluation of the color density of the detection unit. Visual evaluation may give different judgments depending on the observer.
【0006】しかし喘息等の対策としての屋内アレルゲ
ン検査等、被検出物の量をできるだけ定量的に把握した
い場合は、上記のような検出方法では十分に対応できな
かった。特に屋内アレルゲンの場合、例えば布団中のダ
ニの量を検査した場合、検査結果に応じて、掃除機等で
ダニを回収する等の早急な対策が必要であり、より定量
的な検出法が求められていた。However, when it is desired to quantitatively determine the amount of an object to be detected as much as possible, such as indoor allergen test as a measure against asthma, etc., the above detection method cannot sufficiently cope with the problem. Especially in the case of indoor allergens, for example, when testing the amount of mites in the futon, urgent measures such as collecting mites with a vacuum cleaner etc. are required according to the test results, and a more quantitative detection method is required. Had been.
【0007】[0007]
【発明が解決しようとする課題】本発明の目的は、溶液
中に採取した屋内アレルゲン等を簡便迅速に検出できる
とともに、その存在量を目視により定量的に測定できる
免疫検査体を提供することである。SUMMARY OF THE INVENTION An object of the present invention is to provide an immunological test body which can easily and quickly detect indoor allergens and the like collected in a solution and can quantitatively measure the amount of the allergens visually. is there.
【0008】[0008]
【課題を解決するための手段】本発明は、一方はクロマ
ト展開可能な基材に固定されており、他方は着色微粒子
と結合してクロマト展開前方に溶解可能な形で基材に保
持されている2種類の抗体対を含んでなる免疫検査体に
おいて、検出部がクロマト展開後方に沿って分離された
複数の検出帯で形成されていることを特徴とする免疫検
査体に関する。詳しくは、本発明は、複数の検出帯のう
ち上流の検出帯を形成する固定抗体の抗原捕捉能が抗原
を捕捉することにより飽和したのちは、より下流の検出
帯により抗原を捕捉するようにした上記の免疫検査体に
関する。より詳しくは、本発明は、各検出帯が、標識抗
体と抗原が結合したラベル化抗原を捕捉したことにより
生じる呈色の濃度がもはや捕捉したラベル化抗原の量を
反映しなくなるよりも少ない量の抗原量で飽和する量の
抗体を固定してなる上記の免疫検査体。The present invention is characterized in that one is fixed to a chromatographically developable base material, and the other is held by the base material in a form capable of binding to colored fine particles and dissolving ahead of the chromatographic spread. The present invention relates to an immunological test specimen comprising two types of antibody pairs, wherein the detection portion is formed by a plurality of detection zones separated along the back of the chromatograph. Specifically, the present invention is to capture the antigen by capturing the antigen after the antigen capturing ability of the immobilized antibody forming the upstream detection band among the plurality of detection bands is saturated, so as to capture the antigen by the downstream detection band. The present invention relates to the above-mentioned immunoassay. More specifically, the present invention provides a method wherein each detection zone has an amount of color generated by capturing a labeled antigen to which a labeled antibody and an antigen are bound, such that the concentration of coloration no longer reflects the amount of the captured labeled antigen. The above-mentioned immunological test body, wherein the antibody is fixed in an amount that saturates with the amount of antigen.
【0009】また本発明は、抗原を溶解した液を上記免
疫検査体を用いてクロマト展開し、ラベル化抗原と結合
することにより呈色した検出帯の位置または本数から、
上記液中に溶解した抗原の量を測定するアレルゲンの検
査方法に関する。更にまた、本発明は、検体採取部、抗
原溶解液収納部および上記免疫検査体を含んでなるアレ
ルゲン検査キットに関する。加えて、本発明は、検体採
取部で検体を採取したのち、キットの所定部分に取り付
けて検体を測定することのできる、検体採取部が着脱可
能な上記のアレルゲン検体キットに関する。Further, the present invention provides a method wherein the solution in which an antigen is dissolved is subjected to chromatographic development using the above-mentioned immunoassay, and the position or the number of detection bands colored by binding to a labeled antigen is
The present invention relates to an allergen test method for measuring the amount of antigen dissolved in the liquid. Furthermore, the present invention relates to an allergen test kit comprising a sample collection section, an antigen solution storage section, and the above-mentioned immunoassay. In addition, the present invention relates to the above-mentioned allergen sample kit, which is detachable from the sample collection unit and can be attached to a predetermined portion of the kit and measure the sample after the sample is collected by the sample collection unit.
【0010】[0010]
【発明の実施の形態】本発明の免疫検査体は、検出部が
クロマト展開後方に沿って分離された複数の検出帯で形
成されていることを特徴とする。これにより、複数の検
出帯のうち上流の検出帯を形成する固定抗体の抗原捕捉
能が抗原を捕捉することにより飽和したのちは、より下
流の検出帯により抗原を捕捉するようにしたところに特
徴がある。本発明の免疫検査体を用いて、抗原を溶解し
た液をクロマト展開し、ラベル化抗原と結合することに
より呈色した検出帯の位置を観察することによって、上
記液中に溶解した抗原の量を測定することができる。BEST MODE FOR CARRYING OUT THE INVENTION The immunoassay according to the present invention is characterized in that the detection section is formed of a plurality of detection zones separated along the back of the chromatograph. Thereby, after the antigen-capturing ability of the immobilized antibody forming the upstream detection band among the plurality of detection bands is saturated by capturing the antigen, the antigen is captured by the downstream detection band. There is. Using the immunoassay of the present invention, the solution in which the antigen was dissolved was chromatographed, and the position of the detection band colored by binding to the labeled antigen was observed to determine the amount of the antigen dissolved in the solution. Can be measured.
【0011】本発明において、検出部がクロマト展開後
方に沿って分離された複数の検出帯で形成されていると
は、標識抗体と結合したラベル化抗原と結合してサンド
イッチ複合体を形成することのできる抗体を固定した検
出部が、単一のゾーンでなく複数のゾーンとして形成さ
れ、各検出帯がクロマト展開の方向に並べて配置されて
いることを言う。In the present invention, the expression that the detection portion is formed by a plurality of detection bands separated along the back of the chromatograph means that a detection complex is bound to a labeled antigen bound to a labeled antibody to form a sandwich complex. This means that the detection section on which the antibody capable of immobilization is formed is formed not as a single zone but as a plurality of zones, and the respective detection bands are arranged side by side in the direction of chromatographic development.
【0012】以下、図を用いて本発明を説明する。図2
は本発明の免疫検査体を示す。図2中3は複数の検出帯
4(4-1、4-2、4-3、・・・・4-n)からなる抗
原検出部である。免疫検査体1の基材8上に、上流部か
ら順に浸漬部6、標識抗体保持部2、検出部3、試験終
了確認部5および吸液部7が設けられている。抗原を溶
解した溶解液に本免疫検査体の浸漬部6が浸されると、
基材8により溶解液が吸い上げられてクロマト展開が開
始される。溶解液が標識抗体が保持された位置2に来る
と、抗原は標識抗原と結合してラベル化抗原となって、
更に下流へ移動する。ラベル化抗原は固定抗体が固定さ
れた位置、即ち検出部3に到達すると固定抗体と結合
し、そこに捕捉されるとともに検出部を着色する。溶解
液(一般にはこの媒体が展開液を兼ねている)が標識抗
体の所に達すると、標識抗体の一部は抗原と結合するこ
となく、そのまま溶解液によって下流へ運ばれる。標識
抗体そのものは固定抗体と結合することはできないた
め、検出部を通過して更に下流に設置された試験終了確
認部5に達する。試験終了確認部は標識抗体と結合する
ことのできる抗体が固定されて形成されているため、運
ばれてきた標識抗体はここで捕捉されて試験終了確認部
を着色する。これにより試験が正常に行われ、終了した
ことが確認される。The present invention will be described below with reference to the drawings. FIG.
Indicates an immunological test article of the present invention. In FIG. 2, reference numeral 3 denotes an antigen detection unit composed of a plurality of detection bands 4 (4-1, 4-2, 4-3,..., 4-n). An immersion section 6, a labeled antibody holding section 2, a detection section 3, a test end confirmation section 5, and a liquid absorption section 7 are provided on a base material 8 of the immunological test body 1 in order from the upstream. When the immersion part 6 of the present immunological test specimen is immersed in a solution in which the antigen has been dissolved,
The dissolving solution is sucked up by the base material 8 and chromatograph development is started. When the lysate comes to position 2 where the labeled antibody is retained, the antigen binds to the labeled antigen and becomes a labeled antigen,
Move further downstream. When the labeled antigen reaches the position where the immobilized antibody is immobilized, that is, reaches the detection unit 3, it binds to the immobilized antibody, is captured there, and colors the detection unit. When the lysate (generally, this medium also serves as a developing solution) reaches the labeled antibody, a part of the labeled antibody is directly carried downstream by the lysate without binding to the antigen. Since the labeled antibody itself cannot bind to the immobilized antibody, it passes through the detection unit and reaches the test completion confirmation unit 5 provided further downstream. Since the test completion confirmation section is formed by fixing an antibody capable of binding to the labeled antibody, the transported labeled antibody is captured here and the test completion confirmation section is colored. This confirms that the test has been performed normally and has been completed.
【0013】図1に示す従来のイムノクロマト法に基づ
く検査体では、抗原検出部3は単一部分からなる。検出
部はラベル化抗原を捕捉することにより着色するが、そ
の色の濃度は捕捉されたラベル化抗原の量に依存する。
捕捉された抗原の量は目視でもある程度判定可能である
が、抗原溶解液の流れ方によっては着色状況が変わるた
め、色見本の利用も難しく、抗原量を明示するできるも
のとはなっていない。In the test body based on the conventional immunochromatography method shown in FIG. 1, the antigen detecting section 3 has a single part. The detection unit is colored by capturing the labeled antigen, and the concentration of the color depends on the amount of the captured labeled antigen.
Although the amount of the captured antigen can be visually determined to some extent, the coloring state changes depending on the flow of the antigen solution, making it difficult to use a color sample and making it impossible to clearly indicate the amount of the antigen.
【0014】本発明では、図2に示すように抗原検出部
3は複数の検出帯4でできており、第1の検出帯4-1
で色の変化がもはや識別できなくなるような量の抗原が
存在する場合には、第1検出帯のラベル化抗原捕捉能が
飽和するように設計されている。したがって、第1検出
帯でラベル化抗原の捕捉量に対応するような十分な色の
変化が得られなくなった時点を越えて送られて来るラベ
ル化抗原は第1検出帯を通り抜け第2の検出帯4-2に
捕捉されるようになる。即ち、第2の検出帯が呈色する
ようになる。第2以降の検出帯も同じように限界捕捉量
が設定されている。したがって存在する抗原の量が多く
なるにつれて、上流から順に呈色した検出帯の数が増加
し、これによって抗原の存在量範囲を把握することがで
きる。In the present invention, as shown in FIG. 2, the antigen detecting section 3 is made up of a plurality of detection zones 4 and a first detection zone 4-1.
In the case where there is an amount of antigen such that the color change can no longer be discriminated, the first detection zone is designed to saturate the ability to capture the labeled antigen. Therefore, the labeled antigen sent beyond the point in time at which a sufficient color change corresponding to the amount of the labeled antigen captured in the first detection zone cannot be obtained passes through the first detection zone and the second detection zone. It will be captured by obi 4-2. That is, the second detection band becomes colored. The limit capture amount is set in the same manner in the second and subsequent detection bands. Therefore, as the amount of the present antigen increases, the number of the detection bands colored in order from the upstream increases, whereby the range of the abundance of the antigen can be grasped.
【0015】各検出帯の大きさはそれぞれ異なってもよ
いし、同じであってもよいが、特に違える必要がなけれ
ば同じ大きさでよい。また各検出帯の配置間隔もそれぞ
れ異なってもよいし、同じであってもよいが、特に違え
る必要がなければ同じ間隔でよい。この間隔は別の検出
帯であることが容易に識別できる範囲でできるだけ接近
して設けられることが検出体の寸法を過大にしないため
好ましい。また、各検出帯の形は図2に示すようなライ
ン状であったもよいし、円形、矩形その他の形でもよ
い。色の違いを容易に識別できる範囲であればできるだ
け小さい方が好ましい。The size of each detection band may be different or the same, but may be the same unless it is necessary to make a difference. Also, the arrangement intervals of the respective detection bands may be different or the same, but may be the same unless there is a particular need. This interval is preferably provided as close as possible within a range in which it can be easily identified as another detection band so as not to make the size of the detection object excessive. Further, the shape of each detection band may be a line as shown in FIG. 2, or may be a circle, a rectangle, or another shape. It is preferable that the difference be as small as possible as long as the difference in color can be easily identified.
【0016】検出部および試験終了確認部には表示窓を
開けたカバー9をかけてもよく、その方が外観が美しく
できるが、必ずしも必要とはしない。A cover 9 having an open display window may be applied to the detecting section and the test end confirming section, which can make the appearance beautiful, but is not always necessary.
【0017】このようなイムノクロマト法では、存在す
る抗原量に対して標識抗体の量が十分に多くないと、標
識抗体と結合することなく固定抗体に到達して固定抗体
に捕捉される抗原が存在するようになる。この場合には
固定抗体は呈色することなく消耗されるため、そうでな
い場合に比べて抗原量がより少ない評価結果となる。こ
れは従来の方法に留まらず、本発明の場合にも当てはま
る。したがってクロマト基材に保持される標識抗体の量
は抗原量に比べて十分多くする必要がある。あるいは本
発明の免疫検査体を使用するに際しては、基材に保持さ
れた標識抗体の量を考慮して、試料中の抗原の量を少な
くして測定を行うことが好ましい。In such an immunochromatography method, if the amount of the labeled antibody is not sufficiently large with respect to the amount of the existing antigen, the amount of the antigen that reaches the immobilized antibody without being bound to the labeled antibody and is captured by the immobilized antibody is present. I will be. In this case, since the immobilized antibody is consumed without coloring, the evaluation result is smaller in the amount of antigen than in the case where it is not. This applies not only to the conventional method but also to the present invention. Therefore, the amount of the labeled antibody retained on the chromatographic substrate must be sufficiently larger than the amount of the antigen. Alternatively, when using the immunological test article of the present invention, it is preferable to reduce the amount of the antigen in the sample and perform the measurement in consideration of the amount of the labeled antibody retained on the substrate.
【0018】また、検出部においては、ラベル化抗原が
固定抗体と反応する速度が遅いと、検出帯を素通りする
ものが現れ、上流の検出帯が飽和する前に、より下流の
検出帯に到達してこれを呈色してしまうため、測定結果
を誤らせる場合ある。これを避けるために、ラベル部位
の大きさ、検出部に固定した抗体の密度、抗体-抗原反
応の反応定数、抗原溶解液の展開速度等を適切に設定す
ること必要である。これは実験により適切に確立するこ
とができる。In the detection section, if the rate at which the labeled antigen reacts with the immobilized antibody is low, some may pass through the detection band and reach the downstream detection band before the upstream detection band is saturated. This results in a color change, which may result in erroneous measurement results. In order to avoid this, it is necessary to appropriately set the size of the label portion, the density of the antibody immobilized on the detection portion, the reaction constant of the antibody-antigen reaction, the developing speed of the antigen solution, and the like. This can be properly established by experiment.
【0019】本発明において、検出部を構成する抗体お
よび標識抗体を形成する抗体は、評価対象である抗原の
異なるエピトープに結合することのできる抗体であり、
例えば、抗原がダニのアレルゲンの抗原である場合は、
例えば検出部抗体は抗ダニアレルゲン抗体等を、また標
識抗体は検出部抗体とは異なる抗ダニアレルゲン抗体を
使用する。また、試験終了確認部に固定される抗体とし
ては、例えば抗IgG抗体を使用することができる。In the present invention, the antibody constituting the detection section and the antibody forming the labeled antibody are antibodies capable of binding to different epitopes of the antigen to be evaluated,
For example, if the antigen is an antigen of a tick allergen,
For example, the detection section antibody uses an anti-mite allergen antibody, and the labeled antibody uses an anti-mite allergen antibody different from the detection section antibody. In addition, as the antibody immobilized on the test completion confirmation section, for example, an anti-IgG antibody can be used.
【0020】基材はクロマト展開に適したものから選ば
れ、例えば、グラスフィルター、ポリエチレン系不織
布、ポリプロピレン系不織布等が好ましい。グラスフィ
ルターは一般に有機物質との親和性が無視できるため好
ましい。グラスフィルターを使用する場合、その密度お
よび繊度は必要とするクロマト展開速度によって適切に
選ばれる。浸漬部および吸液部は綿状物質または連続気
泡の多孔質材料が使用でき、好ましくは濾紙、メンブレ
ンフィルター、グラスフィルターが用いられる。The substrate is selected from those suitable for chromatographic development. For example, glass filters, polyethylene-based nonwoven fabrics, polypropylene-based nonwoven fabrics and the like are preferable. Glass filters are generally preferred because they have negligible affinity for organic substances. When a glass filter is used, its density and fineness are appropriately selected depending on the required chromatographic development speed. For the immersion part and the liquid absorption part, a cotton-like substance or a porous material having open cells can be used, and preferably a filter paper, a membrane filter, or a glass filter is used.
【0021】[0021]
【実施例】以下、実施例により、具体的に説明する。実施例 1 (1)免疫検査体の作製 1)標識抗体の調製 着色したポリスチレンラテックス(バングス・ラボラト
リーズ(Bangs Laboratories)社製)中に抗体(抗de
r p抗体)を混合し、インキュベートして、抗体をポ
リマー粒子に固定した。The present invention will be specifically described below with reference to examples. Example 1 (1) Preparation of immunoassay 1) Preparation of labeled antibody Antibody (anti-de) was added to colored polystyrene latex (manufactured by Bangs Laboratories).
rp antibody) was mixed and incubated to immobilize the antibody on the polymer particles.
【0022】2)免疫検査体の作製 1cm×15cm(厚さ0.7mm)のグラスフィルタ
ー(ワットマン社製)をクロマト基材として準備した。
クロマト展開の下流に当たる部分に抗原検出用固定抗体
として働く抗ダニアレルゲン抗体液(抗ダニアレルゲン
抗体を生理食塩水中に溶解したものを)1μlずつを1
0mm間隔で太さ3mmの3本のラインとしてピペット
マンで滴下し、次に、更に下流部に、標識抗体と反応し
て試験終了確認用として働く抗IgG抗体液1μlをピ
ペットマンで滴下した。このグラスフィルターを50℃
で1分間乾燥して2種類の抗体をグラスフィルターに固
定した。次に、上で調製した標識抗体を、このグラスフ
ィルターの上流部分に15μl滴下した。標識抗体を滴
下したグラスフィルターを50℃で5分間乾燥して標識
抗体をグラスフィルター上に保持した。上記において、
標識抗体保持部および抗Der p1抗体固定部の第1
の検出帯の位置は、グラスフィルターの検体供与側端部
から、それぞれ3cmおよび4cmであり、この第1の
検出帯から1cmおよび2cmのところに第2および第
3の検出帯を設け、第3の検出帯から更に下流2cmの
ところに抗IgG抗体固定部を形成した。2) Preparation of immunological test specimen A glass filter (manufactured by Whatman) having a size of 1 cm × 15 cm (0.7 mm in thickness) was prepared as a chromatographic substrate.
1 μl of anti-mite allergen antibody solution (anti-mite allergen antibody dissolved in physiological saline) serving as a fixed antibody for antigen detection is applied to a portion corresponding to the downstream portion of the chromatographic development.
Three lines having a thickness of 3 mm were dropped with a pipetteman at 0 mm intervals, and then 1 μl of an anti-IgG antibody solution that reacted with a labeled antibody and served as a confirmation of the end of the test was dropped further down the pipetman. Put this glass filter at 50 ℃
For 1 minute to fix two types of antibodies on a glass filter. Next, 15 μl of the labeled antibody prepared above was dropped on the upstream portion of the glass filter. The glass filter to which the labeled antibody had been dropped was dried at 50 ° C. for 5 minutes to hold the labeled antibody on the glass filter. In the above,
First of labeled antibody holding part and anti-Der p1 antibody fixing part
Are 3 cm and 4 cm from the end of the glass filter on the sample supply side, respectively. The second and third detection bands are provided at 1 cm and 2 cm from the first detection band. An anti-IgG antibody-immobilized portion was formed at a position 2 cm further downstream from the detection band.
【0023】(2)免疫検査体の使用例 1m2の布団に1分間掃除機をかけて採取したゴミを2
0mlの抗原溶解液に混合し、濾過して固形分を除去し
て検体液を調製した。この検体液に、上記で作製した免
疫検査体の最上流部である浸漬部を浸漬し、免疫検査体
を垂直に保持した状態で5秒間静置した。5秒後、検出
部の第1および第2の検出帯および試験終了確認部は標
識微粒子に基づく濃い赤色に着色し、第3の検出帯はわ
ずかに赤色に着色した。第4以降の検出帯にはまったく
変色が認められなかった。[0023] (2) waste that was collected over a period of 1 minute vacuum cleaner to the futon of use example 1m 2 of immunoassay body 2
The mixture was mixed with 0 ml of the antigen solution and filtered to remove solids, thereby preparing a sample solution. The immersion part, which is the uppermost stream of the immunological test specimen prepared above, was immersed in this sample liquid, and left standing for 5 seconds with the immunological test specimen held vertically. After 5 seconds, the first and second detection bands of the detection unit and the test completion confirmation unit were colored deep red based on the labeled fine particles, and the third detection band was slightly colored red. No discoloration was observed in the fourth and subsequent detection bands.
【0024】[0024]
【発明の効果】本発明の免疫検査体は、抗原抗体反応に
より被検体を検出する従来の免疫検査体の限界であった
定量性を改良したものであり、存在する被検体の量を範
囲として検出することができる。したがってこの免疫検
査体を用いてダニ等のアレルゲンを測定することによ
り、アレルゲンの存在量を把握することができ、より適
切な対応を選ぶことが可能となる。The immunoassay of the present invention is an improvement of the quantitative property, which was the limit of the conventional immunoassay for detecting a subject by an antigen-antibody reaction, and the range of the amount of the existing analyte is limited. Can be detected. Therefore, by measuring allergens such as mites using this immune test specimen, the amount of allergens present can be ascertained, and more appropriate measures can be selected.
【図1】 従来の免疫検査体の構成を示す模式図、 (a)側面図、 (b)平面図。FIG. 1 is a schematic view showing a configuration of a conventional immunological test body, (a) a side view, and (b) a plan view.
【図2】 本発明の免疫検査体の構成を示す模式図、 (a)側面図、 (b)平面図。FIG. 2 is a schematic view showing the configuration of the immunological test body of the present invention, (a) a side view, and (b) a plan view.
1:免疫検査体、 2:標識抗体保持部、
3:検出部、 3′:検出表示窓、
4:検出帯 4′:検出帯表示窓、
4-1:第1の検出帯、 4-2:第2の検出
帯、4-n:第n番目の検出帯、 5:試験終了確
認部、5′:試験終了確認部表示窓、 6:浸漬
部、7:吸液部 8:基材、9:カ
バー。1: immunological specimen, 2: labeled antibody holding part,
3: detection unit, 3 ': detection display window,
4: Detection band 4 ': Detection band display window
4-1: first detection band, 4-2: second detection band, 4-n: nth detection band, 5: test end confirmation section, 5 ': test end confirmation section display window, 6: Immersion part, 7: liquid absorption part 8: base material, 9: cover.
Claims (7)
れており、他方は着色微粒子と結合してクロマト展開前
方に溶解可能な形で基材に保持されている2種類の抗体
対を含んでなる免疫検査体において、検出部がクロマト
展開後方に沿って分離された複数の検出帯で形成されて
いることを特徴とする免疫検査体。1. One of them comprises two types of antibody pairs which are fixed to a chromatographically expandable base material and the other are bound to colored fine particles and held on the base material in a form which can be dissolved before chromatographic development. Wherein the detection section is formed by a plurality of detection bands separated along the back of the chromatograph.
する固定抗体の抗原捕捉能が抗原を捕捉することにより
飽和したのちは、より下流の検出帯により抗原を捕捉す
るようにした請求項1記載の免疫検査体。2. The method according to claim 1, wherein after the antigen-capturing ability of the immobilized antibody forming the upstream detection band among the plurality of detection bands is saturated by capturing the antigen, the antigen is captured by the downstream detection band. Item 7. The immunological test according to Item 1.
ラベル化抗原を捕捉したことにより生じる呈色の濃度が
もはや捕捉したラベル化抗原の量を反映しなくなるより
も少ない量の抗原量で飽和する量の抗体を固定してなる
請求項2記載の免疫検査体。3. The amount of antigen in each detection zone is smaller than that in which the concentration of color produced by capturing the labeled antigen in which the labeled antibody and the antigen are bound no longer reflects the amount of the captured labeled antigen. The immunoassay according to claim 2, wherein an amount of the antibody that saturates with is fixed.
記載の免疫検査体を用いてクロマト展開し、ラベル化抗
原と結合することにより呈色した検出帯の位置または本
数から、上記液中に存在する抗原の量を測定するアレル
ゲンの検査方法。4. A solution in which an antigen is dissolved is subjected to chromatographic development using the immunoassay according to claim 2 or 3, and the solution is determined from the position or the number of detection bands colored by binding to a labeled antigen. A method for testing allergens that measures the amount of antigens present in them.
求項1、2または3に記載の免疫検査体を含んでなるア
レルゲン検査キット。5. An allergen test kit comprising a sample collection section, an antigen solution storage section, and the immunological test body according to claim 1, 2, or 3.
トの所定部分に取り付けて検体を測定することのでき
る、検体採取部が着脱可能な請求項5記載のアレルゲン
検体キット。6. The allergen sample kit according to claim 5, wherein after the sample is collected by the sample collection unit, the sample collection unit can be attached to and detached from a predetermined portion of the kit to measure the sample.
浄器、エアコンディショナーまたはふとん乾燥機に取り
付けて使用することのできる請求項5または6に記載の
アレルゲン検体キット。7. The allergen sample kit according to claim 5, wherein at least the sample collection section can be used by being attached to a vacuum cleaner, an air purifier, an air conditioner, or a futon dryer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13021898A JPH11326325A (en) | 1998-05-13 | 1998-05-13 | Immunity inspection body with determination efficiency |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13021898A JPH11326325A (en) | 1998-05-13 | 1998-05-13 | Immunity inspection body with determination efficiency |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11326325A true JPH11326325A (en) | 1999-11-26 |
Family
ID=15028920
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13021898A Pending JPH11326325A (en) | 1998-05-13 | 1998-05-13 | Immunity inspection body with determination efficiency |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11326325A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002267670A (en) * | 2001-03-07 | 2002-09-18 | Asahi Beer Yakuhin Kk | Method of analyzing specimen by using specific bond |
WO2003014740A1 (en) * | 2001-08-09 | 2003-02-20 | Matsushita Electric Industrial Co., Ltd. | Biosensors and measurement method |
JP2015219191A (en) * | 2014-05-20 | 2015-12-07 | 株式会社ダスキン | Allergen inspection device |
WO2022102607A1 (en) * | 2020-11-10 | 2022-05-19 | プリマハム株式会社 | Allergen detection kit |
-
1998
- 1998-05-13 JP JP13021898A patent/JPH11326325A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002267670A (en) * | 2001-03-07 | 2002-09-18 | Asahi Beer Yakuhin Kk | Method of analyzing specimen by using specific bond |
WO2003014740A1 (en) * | 2001-08-09 | 2003-02-20 | Matsushita Electric Industrial Co., Ltd. | Biosensors and measurement method |
US7790439B2 (en) | 2001-08-09 | 2010-09-07 | Panasonic Corporation | Biosensor and measurement method |
JP2015219191A (en) * | 2014-05-20 | 2015-12-07 | 株式会社ダスキン | Allergen inspection device |
WO2022102607A1 (en) * | 2020-11-10 | 2022-05-19 | プリマハム株式会社 | Allergen detection kit |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3758814B2 (en) | Response signal amplification method in sandwich immunoassay | |
EP1891447B1 (en) | Two step lateral flow assay methods and devices | |
AU2008221293B2 (en) | Diagnostic detection device | |
US4853335A (en) | Colloidal gold particle concentration immunoassay | |
WO2015188633A1 (en) | Immunochromatography detection method and test paper | |
US5955376A (en) | Detection of molecules associated with airborne particles | |
CN101553729A (en) | Saturation assay | |
JP2001033454A (en) | Quantitative method and apparatus for test substance on porous solid phase ligand measurement specimen | |
CN102124341A (en) | Rapid detection of post-vaccination antibody response | |
JP2003215126A (en) | Method for extracting microbe antigen | |
WO2002059569A1 (en) | Collection and analysis of particles | |
JPH11326325A (en) | Immunity inspection body with determination efficiency | |
JP2009192222A (en) | Immunoassay method | |
JP2009192270A (en) | Immunoassay of high sensitivity | |
JP4990692B2 (en) | Immunochromatographic assay and kit | |
JP4426122B2 (en) | Blood antigen detection method and apparatus | |
RU169868U1 (en) | Test system for immunochromatographic determination of procalcitonin in samples of whole blood, serum or plasma for the rapid diagnosis of sepsis | |
JPH11326326A (en) | Immunity inspection body | |
JP3930970B2 (en) | Immunological examination method and immunological examination kit | |
JP3544968B2 (en) | Human hemoglobin detector | |
CN210665764U (en) | P1NP test paper and P1NP detection kit | |
WO2024090518A1 (en) | Immunochromatographic test piece | |
JP6753965B2 (en) | Immunochromatography equipment that reduces background noise and its reduction method | |
JP3930969B2 (en) | Immunological examination method and immunological examination kit | |
TW202449396A (en) | Test strips for lateral flow testing using wet nonwovens for body identification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Effective date: 20050511 Free format text: JAPANESE INTERMEDIATE CODE: A621 |
|
A977 | Report on retrieval |
Effective date: 20060811 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
A131 | Notification of reasons for refusal |
Effective date: 20060815 Free format text: JAPANESE INTERMEDIATE CODE: A131 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20061219 |